135 results
Page 2 of 7
8-K
EX-99.1
rmrmbg2h1zd08z46y
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
8-K
nq2rhey2
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-10.1
klbb3
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
424B4
2bmkerm7r azy654u4
24 May 23
Prospectus supplement with pricing info
4:05pm
8-K
EX-99.1
r9xr2m
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
z9rsklva7
7 Nov 22
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
424B5
4hspkcuqr6atdz sc
23 Aug 22
Prospectus supplement for primary offering
4:30pm
8-K
EX-99.1
x6urj538kjo sw3jtv
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
wblebx692ptlvwqhw9
13 Jul 22
Agile Therapeutics Updates Second Quarter 2022 Guidance
5:20pm
8-K
EX-10.1
xnxx2pdmgs3w7 j82
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm
8-K
fwqlfxa 5bcg
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm
424B4
a3in9h8bsyd46qt3mxhs
5 Jul 22
Prospectus supplement with pricing info
4:26pm